Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.670
-0.040 (-1.48%)
At close: Dec 5, 2025, 4:00 PM EST
2.680
+0.010 (0.37%)
After-hours: Dec 5, 2025, 7:52 PM EST
BDTX Stock Forecast
Stock Price Forecast
The 5 analysts that cover BDTX stock have a consensus rating of "Strong Buy" and an average price target of $10.6, which forecasts a 297.00% increase in the stock price over the next year. The lowest target is $8.00 and the highest is $15.
Price Target: $10.6 (+297.00%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BDTX stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 4 | 4 | 3 |
| Buy | 4 | 3 | 3 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 6 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 4, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $9 | Buy | Initiates | $9 | +237.08% | Nov 18, 2025 |
| Stifel | Stifel | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +199.63% | Oct 16, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +199.63% | Sep 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +274.53% | Aug 11, 2025 |
Financial Forecast
Revenue This Year
71.40M
Revenue Next Year
n/a
from 71.40M
EPS This Year
0.48
from -1.27
EPS Next Year
-0.68
from 0.48
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 73.5M | n/a | ||||
| Avg | 71.4M | n/a | ||||
| Low | 68.6M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 0.64 | -0.20 | ||||
| Avg | 0.48 | -0.68 | ||||
| Low | 0.41 | -0.88 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.